The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / For Myopathy Basic Diagnostic Rules Hold

For Myopathy Basic Diagnostic Rules Hold

November 1, 2010 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF

It’s amazing how far we’ve come—but how far we have to go,” reflected moderator Mary E. Cronin, MD, professor of medicine at the Medical College of Wisconsin in Milwaukee. She was echoing the sentiments of another presenter at the symposium, “Idiopathic Inflammatory Myopathies: Current Concepts,” at the 2009 ACR/ARHP Annual Scientific Meeting in Philadelphia. Paul H. Plotz, MD, chief of the Arthritis and Rheumatism Branch of the National Institute of Arthritis, Musculoskeletal, and Skin Diseases in Bethesda, Md., had just summarized a history of idiopathic inflammatory myopathies (IIM) from 1863 to the present and concluded, “a coherent model of pathogenesis has not yet emerged, a top cytokine has not been identified, and I think we have a long way to go.”

You Might Also Like
  • New Approaches to Inflammatory Myopathy
  • Autoantibodies in Autoimmune Myopathy
  • ACR/ARHP Annual Meeting 2012: Use a Combination of Tests, Patient History, and Physical Exam when Assessing Myopathies
Explore This Issue
November 2010
Also By This Author
  • University of Nebraska Division of Rheumatology and Immunology Makes Education, Clinical Research Top Priorities

In the meantime, according to top investigators, clinicians can rely on foundational diagnostic criteria, track empirical data from investigations of new agents, and look to cross-disciplinary and international collaborations to further our understanding of this complex and heterogeneous group of diseases.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Evaluation: Back to Basics

Robert L. Wortmann, MD, professor of medicine at Dartmouth-Hitchcock Medical Center in Lebanon, N.H., reviewed diagnostic tools for evaluating patients with muscle weakness. Quite often, a thorough history and physical allows clinicians to differentiate between a nerve problem, a muscular problem, or a neuromuscular junction problem, he stated. The basic rules, he said, “hold very well in the clinic, and I ask you not to just blow them off.” Myopathic problems, he noted, are proximal and symmetric, with the remainder of the neurologic exam normal. In contrast, although neuropathic problems can cause proximal muscle weakness, they also cause distal and asymmetric weakness as well as other neurologic abnormalities.

The timed stand test (in which the patient is asked to stand from a chair without using hands for assistance) is an easy test for quantifying lower extremity proximal weakness and is reproducible over time. In patients with proximal muscle weakness, additional findings of high levels of creatine kinase (CK), fatigue, morning stiffness, and weight loss point to differential diagnosis of an inflammatory myopathy, validating the criteria first devised by Bohan and Peter in 1975.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Laboratory tests, especially the muscle enzymes such as CK, aldolase, and succinyl-CoA:3-ketoacid CoA transferase (SCOT), should be measured. “Be aware,” Dr. Wortmann cautioned, “that at any one time, about a third of the population may have a high CK.” High levels can be due to multiple causes, such as racial differences (normal CK levels for black men are at the upper limit of normal in other racial groups); trauma; exercise; and recreational (alcohol, cocaine) and prescribed (statins, HIV medication) drugs.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Education & Training Tagged With: Myopathies, Research, TreatmentIssue: November 2010

You Might Also Like:
  • New Approaches to Inflammatory Myopathy
  • Autoantibodies in Autoimmune Myopathy
  • ACR/ARHP Annual Meeting 2012: Use a Combination of Tests, Patient History, and Physical Exam when Assessing Myopathies
  • Myopathies

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)